For: | Yang HI, Lee MH, Liu J, Chen CJ. Risk calculators for hepatocellular carcinoma in patients affected with chronic hepatitis B in Asia. World J Gastroenterol 2014; 20(20): 6244-6251 [PMID: 24876745 DOI: 10.3748/wjg.v20.i20.6244] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v20/i20/6244.htm |
Number | Citing Articles |
1 |
S. K. Sarin, M. Kumar, G. K. Lau, Z. Abbas, H. L. Y. Chan, C. J. Chen, D. S. Chen, H. L. Chen, P. J. Chen, R. N. Chien, A. K. Dokmeci, Ed Gane, J. L. Hou, W. Jafri, J. Jia, J. H. Kim, C. L. Lai, H. C. Lee, S. G. Lim, C. J. Liu, S. Locarnini, M. Al Mahtab, R. Mohamed, M. Omata, J. Park, T. Piratvisuth, B. C. Sharma, J. Sollano, F. S. Wang, L. Wei, M. F. Yuen, S. S. Zheng, J. H. Kao. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. Hepatology International 2016; 10(1): 1 doi: 10.1007/s12072-015-9675-4
|
2 |
Hwai-I Yang, Mei-Hsuan Lee, Jessica Liu, Hui-Han Hu. Viral Hepatitis in Children. 2019; : 33 doi: 10.1007/978-981-13-0050-9_3
|
3 |
Chien-Jen Chen, Hwai-I Yang, Mei-Hsuan Lee, Jessica Liu, Hui-Han Hu. Hepatitis B Virus in Human Diseases. Molecular and Translational Medicine 2016; : 249 doi: 10.1007/978-3-319-22330-8_12
|
4 |
Hwai-I Yang, Tai-Chung Tseng, Jessica Liu, Mei-Hsuan Lee, Chun-Jen Liu, Tung-Hung Su, Richard Batrla-Utermann, Henry Lik-Yuen Chan, Jia-Horng Kao, Chien-Jen Chen. Incorporating Serum Level of Hepatitis B Surface Antigen or Omitting Level of Hepatitis B Virus DNA Does not Affect Calculation of Risk for Hepatocellular Carcinoma in Patients Without Cirrhosis. Clinical Gastroenterology and Hepatology 2016; 14(3): 461 doi: 10.1016/j.cgh.2015.10.033
|
5 |
Nicolas Goossens, Yujin Hoshida. Personalized management of hepatocellular carcinoma based on molecular information: Future prospects. Clinical Liver Disease 2015; 5(6): 132 doi: 10.1002/cld.483
|
6 |
Pedro Magalhães-Costa, Luís Lebre, Paula Peixe, Sofia Santos, Cristina Chagas. Hepatocellular Carcinoma in Chronic Hepatitis B Patients on Third Generation Nucleos(t)ides Analogs: Risk Factors and Performance of a Risk Score. GE Portuguese Journal of Gastroenterology 2016; 23(5): 233 doi: 10.1016/j.jpge.2016.02.001
|
7 |
Jessica Liu, Hui-Han Hu, Mei-Hsuan Lee, Masaaki Korenaga, Chin-Lan Jen, Richard Batrla-Utermann, Sheng-Nan Lu, Li-Yu Wang, Masashi Mizokami, Chien-Jen Chen, Hwai-I Yang. Serum Levels of M2BPGi as Short-Term Predictors of Hepatocellular Carcinoma in Untreated Chronic Hepatitis B Patients. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-14747-5
|
8 |
Nicolas Goossens, Yujin Hoshida. Tratamiento personalizado del carcinoma hepatocelular basado en información molecular: perspectivas futuras. Clinical Liver Disease 2016; 8(S1): S43 doi: 10.1002/cld.601
|
9 |
|
10 |
Hui-Han Hu, Jessica Liu, Yu-Ling Lin, Wun-Sheng Luo, Yu-Ju Chu, Chia-Lin Chang, Chin-Lan Jen, Mei-Hsuan Lee, Sheng-Nan Lu, Li-Yu Wang, San-Lin You, Hwai-I Yang, Chien-Jen Chen. The rs2296651 (S267F) variant on NTCP (SLC10A1) is inversely associated with chronic hepatitis B and progression to cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis B. Gut 2016; 65(9): 1514 doi: 10.1136/gutjnl-2015-310686
|
11 |
Justin Chien, Jessica Liu, Mei‐Hsuan Lee, Chin‐Lan Jen, Richard Batrla‐Utermann, Sheng‐Nan Lu, Li‐Yu Wang, San‐Lin You, Hwai‐I Yang, Chien‐Jen Chen. Risk and predictors of hepatocellular carcinoma for chronic hepatitis B patients with newly developed cirrhosis. Journal of Gastroenterology and Hepatology 2016; 31(12): 1971 doi: 10.1111/jgh.13422
|
12 |
Hung-Chih Yang, Tung-Hung Su. Hepatitis B Virus and Liver Disease. 2021; : 205 doi: 10.1007/978-981-16-3615-8_9
|
13 |
Chien-Jen Chen, Mei-Hsuan Lee, Jessica Liu, Hwai-I Yang. Hepatocellular Carcinoma Risk Scores: Ready to Use in 2015?. Hepatic Oncology 2015; 2(1): 1 doi: 10.2217/hep.14.32
|
14 |
Chih-Lin Lin, Jia-Horng Kao. Perspectives and control of hepatitis B virus infection in Taiwan. Journal of the Formosan Medical Association 2015; 114(10): 901 doi: 10.1016/j.jfma.2015.06.003
|
15 |
ZHICHENG YAO, KUNPENG HU, HE HUANG, SHILEI XU, QINGLIANG WANG, PENG ZHANG, PEISHENG YANG, BO LIU. shRNA-mediated silencing of the RFC3 gene suppresses hepatocellular carcinoma cell proliferation. International Journal of Molecular Medicine 2015; 36(5): 1393 doi: 10.3892/ijmm.2015.2350
|
16 |
Josh Hanson, Melissa Fox, Adam Anderson, Penny Fox, Kate Webster, Charlie Williams, Blake Nield, Richard Bagshaw, Allison Hempenstall, Simon Smith, Norma Solomon, Peter Boyd, Yury E Khudyakov. Chronic hepatitis B in remote, tropical Australia; successes and challenges. PLOS ONE 2020; 15(9): e0238719 doi: 10.1371/journal.pone.0238719
|
17 |
Sahar Amirpour-Rostami, Mohammad Kazemi Arababadi. IL-18 and IL-1β Gene Polymorphisms: The Plausible Risk Factors for Chronic Hepatitis B. Viral Immunology 2019; 32(5): 208 doi: 10.1089/vim.2018.0155
|
18 |
Hwai-I Yang, Chien-Jen Chen. Hepatitis B Virus and Liver Disease. 2021; : 143 doi: 10.1007/978-981-16-3615-8_7
|
19 |
L.‐Y. Mak, D. K.‐H. Wong, K.‐S. Cheung, W.‐K. Seto, C.‐L. Lai, M.‐F. Yuen. Review article: hepatitis B core‐related antigen (HBcrAg): an emerging marker for chronic hepatitis B virus infection. Alimentary Pharmacology & Therapeutics 2018; 47(1): 43 doi: 10.1111/apt.14376
|
20 |
Chih‐Lin Lin, Tai‐Chung Tseng, Jia‐Horng Kao. What can we learn from hepatitis B virus clinical cohorts?. Liver International 2015; 35(s1): 91 doi: 10.1111/liv.12716
|
21 |
Chien-Jen Chen, San-Lin You, Wan-Lun Hsu, Hwai-I Yang, Mei-Hsuan Lee, Hui-Chi Chen, Yun-Yuan Chen, Jessica Liu, Hui-Han Hu, Yu-Ju Lin, Yu-Ju Chu, Yen-Tsung Huang, Chun-Ju Chiang, Yin-Chu Chien. Viruses and Human Cancer. Recent Results in Cancer Research 2021; 217: 13 doi: 10.1007/978-3-030-57362-1_2
|